Catastrophic expenditure and treatment attrition in patients seeking comprehensive colorectal cancer treatment in India: A prospective multicentre study

Medicine & Life Sciences

• Health Expenditures 100%
• India 86%
• Multicenter Studies 85%
• Colorectal Neoplasms 78%
• Prospective Studies 62%
• International Normalized Ratio 61%
• National Institutes of Health (U.S.) 27%
• Health Care Costs 24%
• Therapeutics 16%
• Costs and Cost Analysis 11%
• Financial Management 10%
• Lost to Follow-Up 9%
• Insurance 9%
• Global Health 8%
• Tertiary Care Centers 7%
• Income 7%
• Anesthesia 7%
• Radiotherapy 6%
• Cohort Studies 6%
• Drug Therapy 5%
• Neoplasms 2%